Fly News Breaks for February 21, 2018
ONCE
Feb 21, 2018 | 08:36 EDT
Bernstein analyst Vincent Chen lowered his price target for Spark Therapeutics to $60 from $71 saying management's comments bode well for SPK-8011, but RPE65 model update takes down valuation. The analyst reiterates an Outperform rating on the shares.
News For ONCE From the Last 2 Days
There are no results for your query ONCE